Intelligence Β· Clinical Pipeline

SANGAMO THERAPEUTICS Pipeline

All ClinicalTrials.gov programs at SANGAMO THERAPEUTICS β€” phase, modality, and trial IDs.

Programs
1

Quick answer

SANGAMO THERAPEUTICS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TX200-TR101

    SANGAMO THERAPEUTICS, INC

    Kidney Transplant Rejection

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does SANGAMO THERAPEUTICS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs